Key issues in developing antibiotic policies: from an institutional level to Europe-wide. European Study Group on Antibiotic Policy (ESGAP), Subgroup III
- 1 December 2001
- journal article
- Published by Elsevier in Clinical Microbiology & Infection
- Vol. 7, 16-21
- https://doi.org/10.1046/j.1469-0691.2001.00080.x
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Emerging infections—a coordinated European approachClinical Microbiology & Infection, 2001
- Towards a European strategy for controlling antibiotic resistance Nijmegen, Holland August 29–31, 1999Clinical Microbiology & Infection, 2000
- Future needs—clinical services for infectious diseasesClinical Microbiology & Infection, 2000
- How do you choose antibiotic treatment? Commentary: Resist jumping to conclusions Commentary: A matter of good clinical practice Commentary: Honesty is the best policyBMJ, 1999
- Antibiotic policy: a tool for controlling resistance of hospital pathogensClinical Microbiology & Infection, 1999
- Strategies for promoting judicious use of antibiotics by doctors and patientsBMJ, 1998
- Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: Guidelines for the Prevention of Antimicrobial Resistance in HospitalsClinical Infectious Diseases, 1997
- The Effect of Changes in the Consumption of Macrolide Antibiotics on Erythromycin Resistance in Group A Streptococci in FinlandNew England Journal of Medicine, 1997
- Strategies to Prevent and Control the Emergence and Spread of Antimicrobial-Resistant Microorganisms in HospitalsJAMA, 1996
- Hospital antibiotic control measures in the UKJournal of Antimicrobial Chemotherapy, 1994